PharmaCyte Biotech, Inc.
PMCB · NASDAQ
4/30/2025 | 4/30/2024 | 4/30/2023 | 4/30/2022 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | $30,656 | $334 | -$4,316 | -$4,239 |
| Dep. & Amort. | $0 | $0 | $0 | $0 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $479 | $1 | $645 | $78 |
| Change in WC | $1,356 | $299 | -$297 | $9 |
| Other Non-Cash | -$35,469 | -$2,785 | $174 | $35 |
| Operating Cash Flow | -$2,978 | -$2,151 | -$3,794 | -$4,117 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | $0 | $0 | $0 | $0 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | -$7,000 | -$5,000 | $0 | $0 |
| Inv. Sales/Matur. | $0 | $0 | $0 | $0 |
| Other Inv. Act. | $0 | $0 | $0 | $0 |
| Investing Cash Flow | -$7,000 | -$5,000 | $0 | $0 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | $0 | $0 |
| Stock Issued | $0 | $33,650 | $1 | $87,362 |
| Stock Repurch. | -$25,029 | -$44,358 | -$13,561 | $0 |
| Dividends Paid | -$1,130 | $0 | $0 | $0 |
| Other Fin. Act. | -$21,357 | $0 | $1 | -$51 |
| Financing Cash Flow | -$25,029 | -$10,708 | -$13,560 | $87,311 |
| Forex Effect | -$0 | -$1 | -$7 | $5 |
| Net Chg. in Cash | -$35,008 | -$17,860 | -$17,361 | $83,199 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $50,180 | $68,040 | $85,401 | $2,202 |
| End Cash | $15,172 | $50,180 | $68,040 | $85,401 |
| Free Cash Flow | -$2,978 | -$2,151 | -$3,794 | -$4,117 |